DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/4qr96b/living_with) has announced the addition of the "Living with Diabetes in France" report to their offering.
In-depth analysis of a large online study amongst 500 patients with Type 2 diabetes, unveiling patients' attitudes, feelings, treatment programmes and needs for coping with diabetes, and includes a full patient segmentation. The study follows on from our original research published in 2009 and provides a current picture of patient attitudes and needs.
This report separates out the findings for the French market from the overall global study. The report is updated at the time of order which can take up to 10 business days.
STAGE 1: Online Patient Study
A quantitative study amongst an international sample of patients with Type 2 Diabetes in the EU, US and emerging markets. A segmentation analysis will be carried out in established markets to include attitudinal statements around treatment, doctor interaction, diet and exercise and compliance. The study includes coverage of oral and injected products, plus BGMs.
STAGE 2: Moderated Online Research Community
Conducted in order to investigate more qualitative interaction capabilities and gather further insights. Patients in Stage 1 will be asked whether they would be amenable to take part in follow-up research. Using the segmentation from Stage 1 as a construct, we will invite respondents who represent each segment (multiple respondents per segment). Issues arising from Stage 1 would be addressed, with a focus on compliance. A one month dialogue will be held among these respondents in a MORC setting.
STAGE 3: Mobile Research
Featuring an innovative, App-based data collection approach focusing on compliance. Research targeting compliance is notoriously difficult because measurement (e.g. diaries) can distort the behaviour you are trying to measure. Our App-based approach will cut through this inherent difficulty and give new access to the real patient situation in relation to compliance with therapy, diet & exercise.
Order this insightful report to receive a deeper understanding of:
- Life with diabetes from the patient's perspective
- The filters patients apply to drug decisions
- Insights into the experiences and perceptions that ultimately shape treatment decisions
- An attitudinal segmentation of people with Type 2 diabetes in major markets
Lantus, Humalog, Novorapid, Novomix, Levemir, Humulin, Actrapid, Insuman, Apidra, Insulatard, Victoza, Byetta, Bydureon, Lyxumia, Accu-Chek, One Touch Life Scan, Contour and FreeStyle
For more information visit http://www.researchandmarkets.com/research/4qr96b/living_with
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Source: Research and Markets